China-owned drug plant gets Delaware grants worth $19 million
China's WuXi to build yet another biologics plant, this one with continuous manufacturing | Fierce Pharma
WuXi Biologics
WuXi Biologics Signs Lease for a Clinical Manufacturing Facility in the United States
WuXi Biologics halts trading after US Commerce Department list sparks record 32 per cent slump | South China Morning Post
JLL brokers 68,000 s/f bio-tech lease in Jersey | Real Estate Weekly
WuXi Biologics
WuXi Biologics CEO Named ISPE Annual Meeting Keynoter - Pharmaceutical Processing World
WuXi Biologics on Twitter: "Our facility in Cranbury, New Jersey is focused on biologics development and drug substance GMP clinical-scale manufacturing. https://t.co/RpvNefArAQ #newjersey #biotherapeutics https://t.co/FSLPe4oatr" / Twitter
Biologics: Biologics Bonanza | Site Selection Magazine
Locations & Facilities
WuXi Biologics signs lease for US facility
Cranbury, NJ – R&D and GMP Manufacturing Site (MFG18)